OMIC(Delisted)
Singular Genomics·NASDAQ
--
--(--)
Singular Genomics (OMIC) Financial Statements
Singular Genomics (OMIC) Cash Flow Statement
During Q1 2024, Singular Genomics (OMIC) generated -23.70M in cash flow from operating activities, 31.58M from investing activities, and -- from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q1,2024 | TTM |
|---|
Start Date | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2024 | -- |
End Date | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -4.71M -- | -9.19M -95.05% | -19.84M -115.99% | -17.93M +9.60% | -23.70M -32.17% | -- -- |
Depreciation and Amortization | 152.00K -- | 289.00K +90.13% | 498.00K +72.32% | 831.00K +66.87% | 1.06M +27.32% | -- -- |
Change in Working Capital | 122.00K -- | -908.00K -844.26% | -1.79M -97.69% | 1.16M +164.57% | 594.00K -48.75% | -- -- |
Net Cash Flows from Investing Activities | 2.40M -- | -90.46M -3875.50% | 8.39M +109.27% | 72.94M +769.84% | 31.58M -56.71% | -- -- |
Purchase of PPE and Intangible Assets | 261.00K -- | 507.00K +94.25% | 939.00K +85.21% | 162.00K -82.75% | 25.00K -84.57% | -- -- |
Increase in Investments | 2.04M -- | 101.61M +4888.12% | 35.19M -65.36% | 7.02M -80.06% | 19.18M +173.35% | -- -- |
Net Cash Flows from Financing Activities | 7.51M -- | 133.48M +1677.42% | 23.00K -99.98% | 6.00K -73.91% | -- -- | -- -- |
Change in Capital Stock | 10.00K -- | 2.98M +29740.00% | 23.00K -99.23% | 6.00K -73.91% | -- -- | -- -- |
Increase in Capital Stock | 10.00K -- | 2.98M +29740.00% | 34.00K -98.86% | 13.00K -61.76% | -- -- | -- -- |
Decrease in Capital Stock | -- -- | -- -- | 11.00K -- | 7.00K -36.36% | -- -- | -- -- |
Net Increase in Cash and Cash Equivalents | 5.20M -- | 33.84M +551.11% | -11.43M -133.78% | 55.02M +581.34% | 7.88M -85.68% | -- -- |
Cash and Cash Equivalents at Beginning of Period | 5.52M -- | 12.17M +120.35% | 201.74M +1557.65% | 75.98M -62.34% | 16.83M -77.84% | -- -- |
Cash and Cash Equivalents at End of Period | 10.72M -- | 46.01M +329.18% | 190.31M +313.64% | 130.99M -31.17% | 24.71M -81.14% | -- -- |
You can ask Aime
No Data